The interaction between diabetes, body mass index, hepatic steatosis, and risk of liver resection: Insulin dependent diabetes is the greatest risk for major complications

HPB Surgery

Volumn 2014, Issue , 2014, Pages

  Wiggans, M G ^a,b   Lordan, J T ^a   Shahtahmassebi, G ^c   Aroori, S ^a   Bowles, M J ^a   Stell, D A ^a,b  

^a DERRIFORD HOSPITAL   (United Kingdom)

^b UNIVERSITY OF EXETER   (United Kingdom)

^c NOTTINGHAM TRENT UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84907388814     PISSN: 08948569     EISSN: 16078462     Source Type: Journal    
DOI: 10.1155/2014/586159     Document Type: Article

References (55)

1. O. Farges, B. Malassagne, J. F. Flejou, S. Balzan, A. Sauvanet, and J. Belghiti, "Risk of major liver resection in patients with underlying chronic liver disease: a reappraisal," Annals of Surgery, vol. 229, no. 2, pp. 210-215, 1999.
2. J. Belghiti, K. Hiramatsu, S. Benoist, P. P. Massault, A. Sauvanet, and O. Farges, "Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection," Journal of the American College of Surgeons, vol. 191, no. 1, pp. 38-46, 2000.
3. A. Cucchetti, G. Ercolani, M. Vivarelli et al., "Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis," Liver Transplantation, vol. 12, no. 6, pp. 966-971, 2006.
4. J. T. Mullen, D. Ribero, S. K. Reddy et al., "Hepatic insufficiency and mortality in 1,059 noncirrhotic patients undergoing major hepatectomy," Journal of the American College of Surgeons, vol. 204, no. 5, pp. 854-862, 2007.
5. M. G. Wiggans, G. Shahtahmassebi, M. J. Bowles, S. Aroori, and D. A. Stell, "Renal dysfunction is an independent risk factor for mortality after liver resection and the main determinant of outcome in posthepatectomy liver failure," HPB Surgery, vol. 2013, Article ID 875367, 7 pages, 2013.
6. R. T. Poon, S. T. Fan, C. M. Lo et al., "Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases," Annals of Surgery, vol. 240, no. 4, pp. 698-708, 2004.
7. W. R. Jarnagin, M. Gonen, Y. Fong et al., "Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade," Annals of Surgery, vol. 236, no. 4, pp. 397-407, 2002.
8. K. E. Behrns, G. G. Tsiotos, N. F. DeSouza, M. K. Krishna, J. Ludwig, and D. M. Nagorney, "Hepatic steatosis as a potential risk factor for major hepatic resection," Journal of Gastrointestinal Surgery, vol. 2, no. 3, pp. 292-298, 1998.
9. R. Veteläinen, A. van Vliet, D. J. Gouma, and T. M. van Gulik, "Steatosis as a risk factor in liver surgery," Annals of Surgery, vol. 245, no. 1, pp. 20-30, 2007.
10. Y. Takahashi, T. Fukusato, A. Inui, and T. Fujisawa, "Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis," World Journal of Gastroenterology, vol. 70, no. 10, pp. 1-29, 2012.
11. J. M. Clark, F. L. Brancati, and A. M. Diehl, "The prevalence and etiology of elevated aminotransferase levels in the United States," American Journal of Gastroenterology, vol. 98, no. 5, pp. 960-967, 2003.
12. S. Chitturi, G. C. Farrell, E. Hashimoto, T. Saibara, G. K. K. Lau, and J. D. Sollano, "Non-alcoholic fatty liver disease in the Asia-Pacific region: definitions and overview of proposed guidelines," Journal of Gastroenterology and Hepatology, vol. 22, no. 6, pp. 778-787, 2007.
13. G. Bedogni, L. Miglioli, F. Masutti, C. Tiribelli, G. Marchesini, and S. Bellentani, "Prevalence of and risk factors for nonalcoholic fatty liver disease: the dionysos nutrition and liver study," Hepatology, vol. 42, no. 1, pp. 44-52, 2005.
14. Y. Falck-Ytter, Z. M. Younossi, G. Marchesini, and A. J. McCullough, "Clinical features and natural history of nonalcoholic steatosis syndromes," Seminars in Liver Disease, vol. 21, no. 1, pp. 17-26, 2001.
15. World Health Organization, Obesity: Preventing and Managing the Global Epidemic, World Health Organization, Geneva, Switzerland, 2000.
16. G. Danaei, M. M. Finucane, Y. Lu et al., "National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants," The Lancet, vol. 378, no. 9785, pp. 31-40, 2011.
17. K. Das, K. Das, P. S. Mukherjee et al., "Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease," Hepatology, vol. 51, no. 5, pp. 1593-1602, 2010.
18. J. Vauthey, T. M. Pawlik, D. Ribero et al., "Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases," Journal of Clinical Oncology, vol. 24, no. 13, pp. 2065-2072, 2006.
19. L. Rubbia-Brandt, V. Audard, P. Sartoretti et al., "Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer," Annals of Oncology, vol. 15, no. 3, pp. 460-466, 2004.
20. L. M. DeCarli and C. S. Lieber, "Fatty liver in the rat after prolonged intake of ethanol with a nutritionally adequate new liquid diet.," Journal of Nutrition, vol. 91, no. 3, pp. 331-336, 1967.
21. V. E. de Meijer, B. T. Kalish, M. Puder, and J. N. M. IJzermans, "Systematic review and meta-analysis of steatosis as a risk factor in major hepatic resection," British Journal of Surgery, vol. 97, no. 9, pp. 1331-1339, 2010.
22. D. A. Kooby, Y. Fong, A. Suriawinata et al., "Impact of steatosis on perioperative outcome following hepatic resection," Journal of Gastrointestinal Surgery, vol. 7, no. 8, pp. 1034-1044, 2003.
23. D. Gomez, H. Z. Malik, G. K. Bonney et al., "Steatosis predicts postoperative morbidity following hepatic resection for colorectal metastasis," The British Journal of Surgery, vol. 94, no. 11, pp. 1395-1402, 2007.
24. L. McCormack, H. Petrowsky, W. Jochum, K. Furrer, and P. Clavien, "Hepatic steatosis is a risk factor for postoperative complications after major hepatectomy: a matched case-control study," Annals of Surgery, vol. 245, no. 6, pp. 923-930, 2007.
25. International Diabetes Federation, "The IDF concensus worldwide definition of the metabolic syndrome," 2006.
26. A. K. Mathur, A. A. Ghaferi, N. H. Osborne et al., "Body mass index and adverse perioperative outcomes following hepatic resection," Journal of Gastrointestinal Surgery, vol. 14, no. 8, pp. 1285-1291, 2010.
27. K. Dhatariya, N. Levy, A. Kilvert et al., "NHS Diabetes guideline for the perioperative management of the adult patient with diabetes," Diabetic Medicine, vol. 29, no. 4, pp. 420-433, 2012.
28. A. Frisch, P. Chandra, D. Smiley et al., "Prevalence and clinical outcome of hyperglycemia in the perioperative period in noncardiac surgery," Diabetes Care, vol. 33, no. 8, pp. 1783-1788, 2010.
29. K. Dhatariya, D. Flanagan, L. Hilton et al., "Management of adults with diabetes undergoing surgery and elective procedures: improving standards," 2011.
30. D. Dindo, N. Demartines, and P.-A. Clavien, "Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey," Annals of Surgery, vol. 240, no. 2, pp. 205-213, 2004.
31. G. P. Copeland, D. Jones, and M. Walters, "POSSUM: a scoring system for surgical audit," The British Journal of Surgery, vol. 78, no. 3, pp. 355-360, 1991.
32. J. Belghiti, P.-A. Clavien, E. Gadzijev et al., "The Brisbane 2000 terminology of hepatic anatomy and resections," The Holiday Property Bond, vol. 2, no. 3, pp. 333-339, 2000.
33. N. N. Rahbari, O. J. Garden, R. Padbury et al., "Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS)," Surgery, vol. 149, no. 5, pp. 713-724, 2011.
34. R. Bellomo, C. Ronco, J. A. Kellum, R. L. Mehta, and P. Palevsky, "Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group," Critical Care, vol. 8, no. 4, pp. R204-R212, 2004.
35. E. M. Brunt, C. G. Janney, A. M. Di Bisceglie, B. A. Neuschwander-Tetri, and B. R. Bacon, "Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions," American Journal of Gastroenterology, vol. 94, no. 9, pp. 2467-2474, 1999.
36. A. Agresti, An Introduction to Categorical Data Analysis, John Wiley & Sons, Hoboken, NJ, USA, 2nd edition, 2002.
37. "R Project for Statistical Computing," 2011, http://www.rproject.org/.
38. C. D. Mann, T. Palser, C. D. Briggs et al., "A review of factors predicting perioperative death and early outcome in hepatopancreaticobiliary cancer surgery," HPB, vol. 12, no. 6, pp. 380-388, 2010.
39. S. Virani, J. S. Michaelson, M. M. Hutter et al., "Morbidity and mortality after liver resection: results of the patient safety in surgery study," Journal of the American College of Surgeons, vol. 204, no. 6, pp. 1284-1292, 2007.
40. A. Andres, C. Toso, B. Moldovan et al., "Complications of elective liver resections in a center with low mortality: a simple score to predict morbidity," Archives of Surgery, vol. 146, no. 11, pp. 1246-1252, 2011.
41. C. Reissfelder, N. N. Rahbari, M. Koch et al., "Postoperative course and clinical significance of biochemical blood tests following hepatic resection," British Journal of Surgery, vol. 98, no. 6, pp. 836-844, 2011.
42. R. M. Pearse, D. A. Harrison, N. MacDonald et al., "Effect of a perioperative, cardiac output-guided hemodynamic therapy algorithm on outcomes following major gastrointestinal surgery: a randomized clinical trial and systematic review," The Journal of the American Medical Association, vol. 311, no. 21, pp. 2181-2190, 2014.
43. H. Abu Daya, M. Eloubeidi, H. Tamim et al., "Opposing effects of aspirin and anticoagulants onmorbidity and mortality in patients with upper gastrointestinal bleeding," Journal of Digestive Diseases, vol. 15, no. 6, pp. 283-292, 2014.
44. J. E. Everhart and K. M. Bambha, "Fatty liver: think globally," Hepatology, vol. 51, no. 5, pp. 1491-1493, 2010.
45. C. Ortiz-Lopez, R. Lomonaco, B. Orsak et al., "Prevalence of prediabetes and diabetes and metabolic profile of patients with Nonalcoholic Fatty Liver Disease (NAFLD)," Diabetes Care, vol. 35, no. 4, pp. 873-878, 2012.
46. S. Romeo, J. Kozlitina, C. Xing et al., "Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease," Nature Genetics, vol. 40, no. 12, pp. 1461-1465, 2008.
47. J. D. Browning, L. S. Szczepaniak, R. Dobbins et al., "Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity," Hepatology, vol. 40, no. 6, pp. 1387-1395, 2004.
48. F. G. Fernandez, J. Ritter, J. W. Goodwin, D. C. Linehan, W. G. Hawkins, and S. M. Strasberg, "Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases," Journal of the American College of Surgeons, vol. 200, no. 6, pp. 845-853, 2005.
49. D. Zorzi, A. Laurent, T. M. Pawlik, G. Y. Lauwers, J. Vauthey, and E. K. Abdalla, "Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases," The British Journal of Surgery, vol. 94, no. 3, pp. 274-286, 2007.
50. M. Shimada, T. Matsumata, K. Akazawa et al., "Estimation of risk of major complications after hepatic resection," American Journal of Surgery, vol. 167, no. 4, pp. 399-403, 1994.
51. A. Taketomi, D. Kitagawa, S. Itoh et al., "Trends in Morbidity and Mortality after Hepatic Resection for Hepatocellular Carcinoma: an Institute's Experience with 625 Patients," Journal of the American College of Surgeons, vol. 204, no. 4, pp. 580-587, 2007.
52. M. Shimada, K. Takenaka, Y. Fujiwara et al., "Risk factors linked to postoperative morbidity in patients with hepatocellular carcinoma," British Journal of Surgery, vol. 85, no. 2, pp. 195-198, 1998.
53. Y.-M. Sun, Y. Su, J. Li, and L.-F. Wang, "Recent advances in understanding the biochemical and molecular mechanism of diabetic nephropathy," Biochemical and Biophysical Research Communications, vol. 433, no. 4, pp. 359-361, 2013.
54. O. H. Hamed, N. H. Bhayani, G. Ortenzi et al., "Simultaneous colorectal and hepatic procedures for colorectal cancer result in increased morbidity but equivalent mortality compared with colorectal or hepatic procedures alone: Outcomes from the National Surgical Quality Improvement Program," HPB, vol. 15, no. 9, pp. 695-702, 2013.
55. P. M. Lykoudis, D. O'Reilly, K. Nastos, and G. Fusai, "Systematic review of surgical management of synchronous colorectal liver metastases," British Journal of Surgery, vol. 101, no. 6, pp. 605-612, 2014.